Helen Sjögren (née Gillgren)
Copenhagen Area, Capital Region, Denmark
Principal Scientist at Ferring Pharmaceuticals
Pharmaceuticals
Education
Lund University 1999 — 2005
PhD, Physical Chemistry
The Faculty of Engineering at Lund University 1995 — 1998
MSc, Chemical Engineering
Växjö University 1988 — 1990
BSc, Chemical Engineering
Experience
Ferring Pharmaceuticals July 2015 - Present
Ferring Pharmaceuticals December 2011 - Present
Ferring Pharmaceuticals December 2006 - December 2011
AstraZeneca September 2005 - March 2006
Physical Chemistry 1, Lund University 1999 - 2005
AstraZeneca R&D August 1998 - March 1999
AstraZeneca April 1994 - August 1995
AstraZeneca November 1991 - April 1994
Sandoz September 1990 - September 1991
Skills
Drug Discovery, patent, Drug Development, Dissolution, Regulatory Submissions, Product Development, Quality by Design, colloidal chemistry, Chemistry, protein formulation, Pharmaceutical..., Pharmaceutical Research, Differential Scanning..., CMC, Colloids, Protein Folding, Biopharmaceuticals, Peptides, DLS, Organic Chemistry, pharmaceutical..., Polymers, Technology Transfer, Pharmaceutical R&D, parenteral pharmaceutics, Troubleshooting, Pharmaceutics, Process validation, light scattering, Characterization, physical chemstry, Validation, Protein Chemistry, Pharmaceutical Industry, infertility..., protein stability, Lifesciences, Surface Chemistry, Chromatography, GMP, Formulation, Drug Delivery, CD spectroscopy, protein aggregation, DSC, Analytical Chemistry, Surfactants, AFM, Innovation, GxP